Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients ; volume:22 ; number:1 ; day:2 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
BMC cancer ; 22, Heft 1 (2.6.2022), 1-13, 12.2022
- Urheber
-
Al-Mterin, Mohammad A.
Murshed, Khaled
Alsalman, Alhasan
Abu-Dayeh, Ala
Elkord, Eyad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09710-1
- URN
-
urn:nbn:de:101:1-2022080119264954024263
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Mterin, Mohammad A.
- Murshed, Khaled
- Alsalman, Alhasan
- Abu-Dayeh, Ala
- Elkord, Eyad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of NK cell and Treg subsets in renal transplantation
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Grundlagen: Signalwege und Checkpoints
mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
Pathological conditions re-shape physiological Tregs into pathological Tregs
Stuttgart Trauba-Treg
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
Targeting immune checkpoints in hematological malignancies
Emerging phagocytosis checkpoints in cancer immunotherapy
Role of NK cell and Treg subsets in renal transplantation
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Grundlagen: Signalwege und Checkpoints
mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
Pathological conditions re-shape physiological Tregs into pathological Tregs
Stuttgart Trauba-Treg
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
Targeting immune checkpoints in hematological malignancies
Emerging phagocytosis checkpoints in cancer immunotherapy
Role of NK cell and Treg subsets in renal transplantation
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Grundlagen: Signalwege und Checkpoints
mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
Pathological conditions re-shape physiological Tregs into pathological Tregs
Stuttgart Trauba-Treg
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
Targeting immune checkpoints in hematological malignancies